ArticleThe Lancet. Infectious diseases2022

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.

Thiago Cerqueira-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.